Edition:
United States

Interleukin Genetics Inc (ILIU.PK)

ILIU.PK on OTC Markets Group

0.00USD
20 Sep 2017
Change (% chg)

$-0.00 (-4.76%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
140,400
Avg. Vol
159,885
52-wk High
$0.20
52-wk Low
$0.00

Latest Key Developments (Source: Significant Developments)

Interleukin genetics says adoption plan to wind-up and liquidate company subject to shareholder approval via a proxy statement
Monday, 24 Jul 2017 04:49pm EDT 

July 24 (Reuters) - Interleukin Genetics Inc :Interleukin Genetics Inc - adoption plan to wind-up and liquidate company subject to shareholder approval via a proxy statement.Interleukin Genetics Inc says appointment of Barry Kallander of Kallandergroup, Inc as director and president, secretary and treasurer.  Full Article

Interleukin Genetics to wind-up and pursue liquidation plan
Monday, 24 Jul 2017 04:29pm EDT 

July 24 (Reuters) - Interleukin Genetics Inc :Interleukin Genetics to wind-up and pursue a plan of liquidation.Interleukin Genetics Inc - ‍as a result of the developments, co will not be able to file quarterly report on form 10-Q for quarter ended June 30, 2017​.Interleukin Genetics Inc - ‍as of July 21, 2017, company had cash on hand of approximately $484,000​.Interleukin Genetics Inc - ‍board has directed that form 10-Q not be filed in order to preserve capital for satisfaction of debts and shareholders​.Interleukin Genetics - liquidation is subject to shareholder approval via proxy statement with a special meeting of shareholders to be held in August.  Full Article

Interleukin Genetics to explore strategic alternatives, reduce workforce
Monday, 3 Jul 2017 08:00am EDT 

July 3 (Reuters) - Interleukin Genetics Inc :Interleukin genetics to explore strategic alternatives, reduce workforce.Interleukin genetics- will reduce company's workforce by five employees (63%) as part of plan to reduce operating costs.Interleukin genetics inc - as part of restructuring, company also announced that it is shutting down its ilustra inflammation management program.Interleukin genetics inc - co will likely not be able to file its quarterly report on form 10-q for quarter ended june 30, 2017 on a timely basis.  Full Article

Interleukin Genetics posts Q2 loss of $0.01/share
Tuesday, 16 Aug 2016 08:00am EDT 

Interleukin Genetics Inc: Interleukin Genetics reports second quarter 2016 financial results . Q2 revenue $590,000 versus $376,000 .Q2 loss per share $0.01.  Full Article

Interleukin Q1 loss per share $0.01
Monday, 16 May 2016 08:00am EDT 

Interleukin Genetics Inc : Interleukin genetics reports first quarter 2016 financial results . Q1 loss per share $0.01 .Q1 revenue $961,000 versus $403,000.  Full Article